At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,814 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
In Brief
An observational study for Parkinson's Disease. Completed, enrolled 1,814 participants across 284 sites in 7 countries.
Detailed Summary
The general aim of this non-interventional study is to assess the safety and efficacy of pramipexole extended release in patients with Parkinson's disease in routine clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesAustria, Estonia, Kazakhstan, Romania, Serbia, Slovakia, Slovenia
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedFeb 2010
Primary CompletionJun 2013
TodayJul 2026
First PostedFeb 3, 2010
Enrollment StartNov 1, 2009
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 16.4 years ago